Teva to pay $1.2 bn fine to settle US antitrust case
Teva Pharmaceutical will pay $1.2 billion to settle US antitrust charges in a long-running "pay for delay" case involving Cephalon, which Teva acquired in 2012, the Federal Trade Commission said Thursday.
May 28, 2015, 22:21 PM IST